ALGN 📈 Align Technology - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0162551016
ALGN: Clear Aligners, Intraoral Scanners, Retention Products, 3D Printing Solutions
Align Technology Inc is a leading medical device company that specializes in designing, manufacturing, and marketing a range of innovative products and services for orthodontists and general practitioner dentists worldwide. The company's product portfolio includes Invisalign clear aligners, which are used to treat various orthodontic conditions, and iTero intraoral scanners, which provide detailed 3D scans of patients' teeth and surrounding tissues. These products are used in the United States, Switzerland, and internationally, and are designed to improve the efficiency and effectiveness of orthodontic treatments.
The company's Clear Aligner segment offers a comprehensive range of products, including the Invisalign comprehensive package, which is designed to address the orthodontic needs of younger patients. This package includes features such as mandibular advancement, compliance indicators, and compensation for tooth eruption, making it an ideal solution for treating complex orthodontic cases. Additionally, the company offers Invisalign First Phase I and Invisalign First Comprehensive Phase 2 packages, which are specifically designed for younger patients between the ages of six and ten years. These packages are designed to address the unique orthodontic needs of this age group, which often involves a mixture of primary and permanent teeth.
Align Technology's Imaging Systems and CAD/CAM Services segment provides a range of products and services, including the iTero intraoral scanning system, which is a single hardware platform that can be used for both restorative and orthodontic procedures. The company also offers restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons, as well as orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. Furthermore, the company provides a range of digital tools, including the Invisalign outcome simulator, which is a chair-side and cloud-based application that allows dentists to simulate the outcome of orthodontic treatments, and the Invisalign progress assessment tool, which enables dentists to track the progress of their patients' treatments.
The company's product portfolio also includes the Align Oral Health Suite, which is a digital interface designed to enhance dental consultations, and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. Additionally, the company offers a range of subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions, which provide dentists with the flexibility to choose the products and services that best meet their needs. With a strong focus on innovation and customer satisfaction, Align Technology Inc has established itself as a leader in the orthodontic industry, and its products and services are used by thousands of dentists and orthodontists worldwide.
Founded in 1997 and headquartered in Tempe, Arizona, Align Technology Inc is a publicly traded company listed on the NASDAQ stock exchange under the ticker symbol ALGN. The company's common stock is classified under the GICS Sub Industry: Health Care Supplies, and its ISIN is US0162551016. With a strong commitment to research and development, Align Technology Inc continues to innovate and expand its product portfolio, providing dentists and orthodontists with the latest technologies and techniques to improve patient outcomes and enhance the overall quality of care.
Additional Sources for ALGN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALGN Stock Overview
Market Cap in USD | 17,735m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 2001-01-26 |
ALGN Stock Ratings
Growth 5y | -35.6% |
Fundamental | 40.2% |
Dividend | - |
Rel. Strength Industry | -546 |
Analysts | 3.94/5 |
Fair Price Momentum | 180.39 USD |
Fair Price DCF | 90.89 USD |
ALGN Dividends
No Dividends PaidALGN Growth Ratios
Growth Correlation 3m | -9.2% |
Growth Correlation 12m | -82.2% |
Growth Correlation 5y | -33.6% |
CAGR 5y | -4.80% |
CAGR/Mean DD 5y | -0.12 |
Sharpe Ratio 12m | -0.61 |
Alpha | -67.06 |
Beta | 1.74 |
Volatility | 43.20% |
Current Volume | 556.7k |
Average Volume 20d | 653.5k |
As of December 28, 2024, the stock is trading at USD 215.50 with a total of 556,746 shares traded.
Over the past week, the price has changed by +0.90%, over one month by -5.45%, over three months by -13.61% and over the past year by -21.40%.
Partly, yes. Based on ValueRay Fundamental Analyses, Align Technology (NASDAQ:ALGN) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.19 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALGN as of December 2024 is 180.39. This means that ALGN is currently overvalued and has a potential downside of -16.29%.
Align Technology has received a consensus analysts rating of 3.94. Therefor, it is recommend to buy ALGN.
- Strong Buy: 7
- Buy: 3
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, ALGN Align Technology will be worth about 205.1 in December 2025. The stock is currently trading at 215.50. This means that the stock has a potential downside of -4.81%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 263.7 | 22.3% |
Analysts Target Price | 270.4 | 25.5% |
ValueRay Target Price | 205.1 | -4.8% |